ESC 365 - Doctor Panagiota Efstathia Nikolaou

Speaker illustration

Doctor Panagiota Efstathia Nikolaou

National & Kapodistrian University of Athens, Athens (Greece)

Member of:

Empagliflozin treatment pre- and post- acute myocardial infarction reduces no-reflow, inflammatory cell infiltration and infarct size while preserving cardiac function.

Event: ESC Congress 2024

Topic: No Reflow

Session: Basic research in acute coronary syndromes

Discovery and in vivo evaluation of novel inhibitors of the hydrolytic activity of mitochondrial F1Fo ATP synthase to alleviate myocardial ischemia reperfusion injury

Event: ESC Congress 2023

Topic: Ischaemia, Infarction, Cardioprotection

Session: Ischaemia reperfusion

Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells.

Event: ESC Congress 2023

Topic: Ischaemia, Infarction, Cardioprotection

Session: Ischaemia reperfusion

Cardiotoxicity in light chain amyloidosis: Insights from the first murine model with intramyocardial injection of patient-derived amyloidogenic light chains

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Elucidating basic mechanisms in heart failure

Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

Event: ESC Congress 2022

Topic: Ischaemia, Infarction, Cardioprotection

Session: Myocardial ischaemia and protective mechanisms

Understanding the molecular mosaic of cardiotoxicity of light chains in plasma cell dyscrasias and cardiac light chain amyloidosis with the use of patient derived full-length light chains

Event: ESC Congress 2022

Topic: Cardiomyopathies

Session: Cardiomyopathies

Empagliflozin rescues primary murine cardiac fibroblasts, but not cardiomyocytes, from hypoxia-reoxygenation injury through STAT3-mediated cascades.

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: Anti-diabetic pharmacotherapy in clinical practice

Al amyloidosis with cardiac involvement: cardiotoxicity of aggregation prone peptides deriving from variable domains of immunoglobulin light chains

Event: ESC Congress 2020

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Mechanisms of Heart Failure and Implications for Clinical Translation

Hydrolytic activity of mitochondrial F1Fo ATP synthase as a target for myocardial ischemia: discovery and in vitro evaluation of novel inhibitors

Event: ESC Congress 2020

Topic: Mitochondria

Session: Mitochondria and Metabolism in Cardiovascular Disease

Investigating the impact of aging and hyperlipidaemia on metformin cardioprotection against carfilzomib-induced cardiotoxicity in vivo

Event: ESC Congress 2020

Topic: Cardiotoxicity of Drugs

Session: Pharmacology and Pharmacotherapy ePosters

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources